Systemic Scleroderma Treatment Market Forecast Highlighting Advances in Autoimmune Care
Systemic scleroderma, also known as systemic sclerosis, is a rare autoimmune disease characterized by excessive collagen production, progressive skin thickening, and damage to internal organs such as the lungs, heart, kidneys, and gastrointestinal tract. Although the condition remains incurable, advances in rheumatology therapeutics, the expanding rare disease treatment market, and innovative immunosuppressive therapies are significantly improving disease management and...